We came across a bullish thesis on Vera Therapeutics, Inc. on Valueinvestorsclub.com by yarak775. In this article, we will summarize the bulls’ thesis on VERA. Vera Therapeutics, Inc.'s share was trading at $45.11 as of January 28th.
[caption id="attachment_575379" align="aligncenter" width="750"]Vera Therapeutics (VERA) is a clinical-stage biotechnology company focused on developing biologic therapies for autoimmune diseases, with its investment case centered almost entirely on a single, highly de-risked asset: atacicept. Atacicept...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.